Annual SG&A:
$314.93M+$29.07M(+10.17%)Summary
- As of today (October 5, 2025), ASND annual SG&A is $314.93 million, with the most recent change of +$29.07 million (+10.17%) on December 31, 2024.
- During the last 3 years, ASND annual SG&A has risen by +$125.60 million (+66.34%).
- ASND annual SG&A is now at all-time high.
Performance
ASND SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$106.35M(-100.00%)Summary
- As of today (October 5, 2025), ASND quarterly SG&A is $0.00, with the most recent change of -$106.35 million (-100.00%) on June 1, 2025.
- Over the past year, ASND quarterly SG&A has dropped by -$80.00 million (-100.00%).
- ASND quarterly SG&A is now -100.00% below its all-time high of $106.35 million, reached on March 31, 2025.
Performance
ASND Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$11.49B-$3.13B(-37.42%)Summary
- As of today (October 5, 2025), ASND TTM SG&A is -$11.49 billion, with the most recent change of -$3.13 billion (-37.42%) on June 1, 2025.
- Over the past year, ASND TTM SG&A has dropped by -$11.78 billion (-4056.97%).
- ASND TTM SG&A is now -1894.99% below its all-time high of $640.36 million.
Performance
ASND TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
ASND Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +10.2% | -100.0% | -4057.0% |
| 3Y3 Years | +66.3% | -100.0% | -5447.9% |
| 5Y5 Years | +480.5% | -100.0% | -10000.0% |
ASND Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +66.3% | -100.0% | at low | -96.0% | at low |
| 5Y | 5-Year | at high | +480.5% | -100.0% | at low | -244.6% | at low |
| All-Time | All-Time | at high | +9718.4% | -100.0% | at low | -1895.0% | at low |
ASND Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $183.06M(-30.4%) |
| Mar 2025 | - | $106.35M(>+9900.0%) | $263.06M(+14.8%) |
| Dec 2024 | $314.93M(+10.2%) | $0.00(-100.0%) | $229.20M(-23.1%) |
| Sep 2024 | - | $76.71M(-4.1%) | $298.00M(+2.6%) |
| Jun 2024 | - | $80.00M(+10.4%) | $290.48M(+1.2%) |
| Mar 2024 | - | $72.48M(+5.4%) | $286.97M(+0.4%) |
| Dec 2023 | $285.86M(+22.9%) | $68.80M(-0.6%) | $285.88M(+4.0%) |
| Sep 2023 | - | $69.20M(-9.5%) | $274.77M(+3.0%) |
| Jun 2023 | - | $76.49M(+7.1%) | $266.65M(+6.5%) |
| Mar 2023 | - | $71.39M(+23.8%) | $250.38M(+7.8%) |
| Dec 2022 | $232.50M(+22.8%) | $57.69M(-5.6%) | $232.18M(+1.1%) |
| Sep 2022 | - | $61.08M(+1.4%) | $229.71M(+6.9%) |
| Jun 2022 | - | $60.22M(+13.2%) | $214.93M(+8.9%) |
| Mar 2022 | - | $53.20M(-3.7%) | $197.33M(+4.4%) |
| Dec 2021 | $189.33M(+116.6%) | $55.21M(+19.2%) | $188.99M(+19.5%) |
| Sep 2021 | - | $46.30M(+8.7%) | $158.13M(+19.5%) |
| Jun 2021 | - | $42.61M(-5.0%) | $132.31M(+17.5%) |
| Mar 2021 | - | $44.86M(+84.2%) | $112.61M(+28.7%) |
| Dec 2020 | $87.40M(+61.1%) | $24.35M(+18.9%) | $87.48M(+6.6%) |
| Sep 2020 | - | $20.48M(-10.6%) | $82.04M(+12.9%) |
| Jun 2020 | - | $22.91M(+16.1%) | $72.67M(+17.1%) |
| Mar 2020 | - | $19.74M(+4.4%) | $62.08M(+14.6%) |
| Dec 2019 | $54.25M | $18.91M(+70.0%) | $54.19M(+20.9%) |
| Sep 2019 | - | $11.12M(-9.7%) | $44.84M(+7.7%) |
| Jun 2019 | - | $12.32M(+3.9%) | $41.62M(+17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $11.85M(+24.0%) | $35.53M(+20.8%) |
| Dec 2018 | $29.56M(+94.4%) | $9.55M(+20.9%) | $29.41M(+19.2%) |
| Sep 2018 | - | $7.90M(+27.0%) | $24.67M(+22.7%) |
| Jun 2018 | - | $6.22M(+8.6%) | $20.10M(+15.3%) |
| Mar 2018 | - | $5.73M(+19.1%) | $17.43M(+14.3%) |
| Dec 2017 | $15.21M(+19.5%) | $4.81M(+44.2%) | $15.25M(+9.1%) |
| Sep 2017 | - | $3.34M(-6.3%) | $13.98M(+2.9%) |
| Jun 2017 | - | $3.56M(+0.4%) | $13.59M(+4.2%) |
| Mar 2017 | - | $3.54M(+0.1%) | $13.05M(+2.7%) |
| Dec 2016 | $12.73M(+21.9%) | $3.54M(+20.1%) | $12.71M(-2.0%) |
| Sep 2016 | - | $2.95M(-2.2%) | $12.97M(+12.1%) |
| Jun 2016 | - | $3.01M(-6.0%) | $11.57M(+5.9%) |
| Mar 2016 | - | $3.21M(-15.6%) | $10.93M(+41.5%) |
| Dec 2015 | $10.44M(+25.5%) | $3.80M(+144.8%) | $7.72M(+12.2%) |
| Sep 2015 | - | $1.55M(-34.6%) | $6.88M(-6.9%) |
| Jun 2015 | - | $2.37M(>+9900.0%) | $7.39M(+47.3%) |
| Mar 2015 | - | $0.00(-100.0%) | $5.02M(0.0%) |
| Dec 2014 | $8.32M(+159.5%) | $2.96M(+43.4%) | $5.02M(+78.4%) |
| Sep 2014 | - | $2.06M(>+9900.0%) | $2.81M(+83.4%) |
| Jun 2014 | - | $0.00(0.0%) | $1.53M(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) | $1.53M(0.0%) |
| Dec 2013 | $3.21M(-7.2%) | $751.40K(-4.0%) | $1.53M(+96.0%) |
| Sep 2013 | - | $782.60K(>+9900.0%) | $782.60K(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $3.46M | - | - |
FAQ
- What is Ascendis Pharma A/S annual SG&A?
- What is the all-time high annual SG&A for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual SG&A year-on-year change?
- What is Ascendis Pharma A/S quarterly SG&A?
- What is the all-time high quarterly SG&A for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly SG&A year-on-year change?
- What is Ascendis Pharma A/S TTM SG&A?
- What is the all-time high TTM SG&A for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM SG&A year-on-year change?
What is Ascendis Pharma A/S annual SG&A?
The current annual SG&A of ASND is $314.93M
What is the all-time high annual SG&A for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual SG&A is $314.93M
What is Ascendis Pharma A/S annual SG&A year-on-year change?
Over the past year, ASND annual SG&A has changed by +$29.07M (+10.17%)
What is Ascendis Pharma A/S quarterly SG&A?
The current quarterly SG&A of ASND is $0.00
What is the all-time high quarterly SG&A for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly SG&A is $106.35M
What is Ascendis Pharma A/S quarterly SG&A year-on-year change?
Over the past year, ASND quarterly SG&A has changed by -$80.00M (-100.00%)
What is Ascendis Pharma A/S TTM SG&A?
The current TTM SG&A of ASND is -$11.49B
What is the all-time high TTM SG&A for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM SG&A is $640.36M
What is Ascendis Pharma A/S TTM SG&A year-on-year change?
Over the past year, ASND TTM SG&A has changed by -$11.78B (-4056.97%)